There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
Market Cap
31410.10 Cr.Face value
1.00Book value
249.38Div. yield
0.79%P/E ratio
41.67P/B ratio
7.84Debt/Eq.
0.00Market Cap
31410.10 Cr.Face value
1.00Book value
249.38Div. yield
0.79%P/E ratio
41.67P/B ratio
7.84Debt/Eq.
0.00
| Dec 25 | Sep 25 | Change | |
|---|---|---|---|
| Promoter Holdings | 47.55% | 47.56% | -0.01% |
| Promoter Pledge | 0.00% | 0.00% | 0.00% |
J.B. Chemicals Pharmaceuticals, established in 1976, is one of the fastest-growing pharmaceutical companies in India and a leading player in the hypertension and the heart-failure segment. Besides its strong India presence, which accounts for majori Read more 
JB Pharma manufactures and markets pharmaceutical formulations, herbal products, and APIs, while also providing product development services. Its products include oral solids, injectables, liquids, and lozenges across multiple therapeutic areas.
The Company operates in India and exports to over 40 international markets, supported by four international subsidiaries. Generics are exported to the USA, UK, South Africa, Australia, and Canada, while branded generics reach Africa, South-East Asia, the Gulf, the Middle East, Central, and South America.
Exports contribute 38% of total turnover, with the balance from domestic operations. Product-wise, oral solids contribute 56% of turnover, followed by injectables at 22%, liquids at 9%, and lozenges at 5%, together accounting for 90% of total revenue.
